A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.51 USD -0.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Total Liabilities & Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Total Liabilities & Equity
$3.5B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
13%
Johnson & Johnson
NYSE:JNJ
Total Liabilities & Equity
$178.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities & Equity
$94.6B
CAGR 3-Years
-5%
CAGR 5-Years
11%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Liabilities & Equity
$216.2B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Liabilities & Equity
$112.6B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Liabilities & Equity
$71.9B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
7%

See Also

What is Amneal Intermediate Inc's Total Liabilities & Equity?
Total Liabilities & Equity
3.5B USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Total Liabilities & Equity amounts to 3.5B USD.

What is Amneal Intermediate Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
13%

Over the last year, the Total Liabilities & Equity growth was -9%. The average annual Total Liabilities & Equity growth rates for Amneal Intermediate Inc have been -5% over the past three years , -4% over the past five years , and 13% over the past ten years .

Back to Top